Uncategorized
Avedro announces purchase of IROC Innocross business assets
Avedro has acquired the business assets of IROC Innocross AG, expanding Avedro’s portfolio of corneal cross-linking devices and riboflavin brands, according to a company release.IROC Innocross was the first firm to market a cross-linking device for the treatment of keratoconus and other corneal pathologies. The company has sold its UV-X devices to more than 1,000 ophthalmologists and has the largest installed base of cross-linking devices globally, according to the release.